CRBU

Caribou Biosciences Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↓ 4/10
  • Value↓ 0/10
Caribou Biosciences sales and earnings growth
CRBU Growth
Neutral
  • Revenue Y/Y↑ 12.03%
  • EPS Y/Y↑ 12.35%
  • FCF Y/Y↑ 28.51%
Caribou Biosciences gross and profit margin trends
CRBU Profitability
Fair
  • Gross margin ↑ 100.00%
  • EPS margin↓ -1512.80%
  • ROIC 5Y↓ -49.50%
Caribou Biosciences net debt vs free cash flow
CRBU Risk
Great
  • Debt / Equity↓ 0.3
  • Debt / FCF↓ 0.1
  • Interest coverage↓ NA

Caribou Biosciences stock volatility is higher than the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks